Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway
, , and
Apr 13, 2022
About this article
Published Online: Apr 13, 2022
Page range: 389 - 402
Accepted: Dec 14, 2021
DOI: https://doi.org/10.2478/acph-2022-0026
Keywords
© 2022 Qing Su et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Su, Qing
Department of Orthopedic Oncology, Yantai Shan HospitalYantai, China
Xu, Baolin
Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, China
Tian, Zhoubin
Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinan, China
Gong, Ziling
Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalShanghai, China